Healthcare Industry News: Acura Pharmaceuticals
News Release - September 2, 2008
Acura Pharmaceuticals, Inc. Announces Return of President and CEO From Medical Leave
PALATINE, Ill., Sept. 2, 2008 --(HSMN NewsFeed)-- Acura Pharmaceuticals, Inc. (NasdaqCM:ACUR ) announced today that Andy Reddick has resumed full responsibilities as President and Chief Executive Officer following a medical leave of absence initiated in February of this year. The Company expects Mr. Reddick's travel schedule will be limited for the foreseeable future.About Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) (abuse deterrent) Technology and related product candidates. For more information, please visit http://www.acurapharm.com.
Source: Acura Pharmaceuticals
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!